Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Salix discolor pollen is a biological allergen extract derived from the pollen of the American pussy willow (*Salix discolor*). It is primarily utilized as a diagnostic tool in allergy testing, specifically for identifying allergic sensitization through skin prick tests or other diagnostic procedures. The extract contains specific allergenic proteins that trigger a localized immune response in sensitized individuals, allowing clinicians to confirm hypersensitivity to willow pollen, which typically occurs in early spring. As a biologic product, it is manufactured by various specialized allergen extract companies for clinical use in immunology and allergy clinics.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on salix discolor pollen.